{
    "organizations": [],
    "uuid": "22112c8f721b3201ca9abbe824d3fff37aacb027",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-onxeo-announces-start-of-driiv-pha/brief-onxeo-announces-start-of-driiv-phase-1-clinical-study-of-asidna-idUSW8N1KI00S",
    "ord_in_thread": 0,
    "title": "BRIEF-Onxeo Announces Start Of DRIIV Phase 1 Clinical Study Of AsiDNA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " ONXEO SA:\n* DRIIV: FIRST INTERIM RESULTS EXPECTED IN H2 OF 2018 * ANNOUNCES START OF DRIIV, PHASE 1 CLINICAL STUDY OF ASIDNA IN ADVANCED SOLID TUMORS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-25T00:07:00.000+03:00",
    "crawled": "2018-04-25T14:13:35.024+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "onxeo",
        "sa",
        "driiv",
        "first",
        "interim",
        "result",
        "expected",
        "h2",
        "announces",
        "start",
        "driiv",
        "phase",
        "clinical",
        "study",
        "asidna",
        "advanced",
        "solid",
        "tumor",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}